PEC vs Sofiva Genomics: monthly revenue

Monthly revenue and year-on-year change for PEC (6446) and Sofiva Genomics (6615) over the past 13 months. The chart compares year-on-year growth rather than amounts, since the companies differ in size.

Year-on-year change

━ PEC ━ Sofiva Genomics

0%+108%-16%25/1026/0126/0426/0726/10

Monthly revenue history

MonthPECYoYSofiva GenomicsYoY
Oct 2026NT$2.84 billion+102.0%NT$30.2 million-3.0%
Sep 2026NT$2.64 billion+100.0%NT$30.5 million+1.8%
Aug 2026NT$2.62 billion+105.4%NT$30.4 million-2.4%
Jul 2026NT$2.51 billion+92.6%NT$33.7 million+4.3%
Jun 2026NT$2.33 billion+94.9%NT$32.3 million-2.5%
May 2026NT$2.46 billion+108.5%NT$33.7 million-1.7%
Apr 2026NT$2.06 billion+68.3%NT$30.2 million-9.1%
Mar 2026NT$1.94 billion+64.4%NT$34.4 million+2.8%
Feb 2026NT$1.6 billion+56.7%NT$26.4 million-15.7%
Jan 2026NT$1.58 billion+49.8%NT$33.1 million+6.3%
Dec 2025NT$1.92 billion+69.9%NT$33.7 million-3.4%
Nov 2025NT$1.55 billion+53.0%NT$30.9 million-4.9%
Oct 2025NT$1.4 billion+53.6%NT$31.1 million-13.9%

← All Taiwan listed & OTC companies

Sources: Taiwan Stock Exchange, monthly revenue of listed companies (Government Open Data Platform); Taipei Exchange, monthly revenue of OTC companies (TPEx OpenAPI); historical months from MOPS. Amounts in New Taiwan dollars. Changes calculated by this site from the source figures. Not investment advice. Updated: 2026-11-16